Learn about the management of HFrEF and HFpEF from Dr Michelle Kittleson (Cedars-Sinai Heart Institute, Los Angeles, US).

This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.

In this lecture, Dr Kittleson provides an in-depth review of the management of HFrEF and HFpEF. Using recent guidelines and trials such as PARADIGM-HF and STRONG-HF, she highlights the evidence behind current treatment strategies. For HFrEF, Dr Kittleson underscores the importance of quadruple therapy—using ARNI, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors—and shares her own clinical approach. Finally, Dr Kittleson throughly analyses the most effective and least beneficial therapies for HFpEF from the past five years.

Stay tuned for more content from the Cardiomyopathies track of Women As One’s CLIMB® 2025 Skills Training Program.

About Women As One

Women As One is a global organization dedicated to empowering women in cardiology. They offer a variety of resources and programs, including the CLIMB Skills Training Program and the Women As One Talent Directory, a global community of women in cardiology.

Join the Women As One Community
Women physicians who are not yet part of the Women As One community can register for free here.